2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)-
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)- Basic information
- Product Name:
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)-
- Synonyms:
-
- 3-Deoxy Saxagliptin
- Dehydroxy Saxagliptin
- Saxagliptin 3-Deoxy Impurity
- (1S,3S,5S)-2-((S)-2-(adamantan-1-yl)-2-aminoacetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile
- (1S,3S,5S)-2-((S)-2-((3S,5S,7S)-adamantan-1-yl)-2-aminoacetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrochloride(1:1)
- CAS:
- 361441-98-7
- MF:
- C18H25N3O
- MW:
- 299.41
- Mol File:
- 361441-98-7.mol
More
Less
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)- Chemical Properties
- Boiling point:
- 508.7±35.0 °C(Predicted)
- Density
- 1.26±0.1 g/cm3(Predicted)
- pka
- 8.30±0.50(Predicted)
More
Less
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)- Usage And Synthesis
Uses
3-Deoxy Saxagliptin is an impurity of Saxagliptin (S143500); a potent and selective reversible inhibitor of dipeptidyl peptidase-4 (DPP-IV) developed for the treatment of type 2 diabetes.
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)-Supplier
Jiangsu Vcare PharmaTech Co., Ltd.
- Tel
- 13327700685
- sales@vcarepharmatech.com
Shanghai Kewel Chemical Co., Ltd.
- Tel
- 021-64609169 18901607656
- greensnown@163.com
Shenzhen Botel Biotechnology Co. Ltd.
- Tel
- 0755-22202135 13316968096
- 1979313431@qq.com
sgtlifesciences pvt ltd
- Tel
- +8617013299288
- dj@sgtlifesciences.com
Guangzhou Dreampharm Biotechnology Co., Ltd.
- Tel
- 020-36607679 17825480238
- 3008233717@qq.com
More
Less
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)-(361441-98-7)Related Product Information
- BOC-DL-PROLINE ETHYL ESTER
- (1R,3S,5R)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXAMIDE 2,2,2-TRIFLUOROACETIC ACID
- (1S,3R,5S)-2-tert-Butyl 3-ethyl 2-azabicyclo[3.1.0]hexane-2,3-dicarboxylate
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-
- Saxagliptin hydrochloride
- 1H-Pyrrole-1-carboxylic acid, 2-(aMinocarbonyl)-2,3-dihydro-, 1,1-diMethylethyl ester, (2S)-
- (S) - N- Boc- adamantylglycine
- (S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester
- 2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 2-(1,1-dimethylethyl) 3-ethyl ester, (1S,3S,5S)-
- N-Boc-L-trans-4,5-Methanoproline
- (2R)-1,2-Pyrrolidinedicarboxylic acid 1-tert-butyl 2-ethyl ester
- (1S,3S,5S)-2-(TERT-BUTOXYCARBONYL)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID
- DSLXQSYLYSTVKT-ONZQNKQFSA-N
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)-
- AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro-
- Saxagliptin O-β-D-glucuronide
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)-
- N-Boc-L-trans-4,5-methanoproline ethyl ester